EC Number | Application | Comment | Organism |
---|---|---|---|
2.4.2.9 | medicine | increased expression of UPRT may improve the antitumoral effect of 5-fluorouracil and 5-fluorocytosine, and thereby enhance the potential gene-directed enzyme prodrug therapy | Homo sapiens |
3.5.4.1 | pharmacology | applicability of gene-directed enzyme prodrug therapy, feasibility of using magnetic resonance spectroscopy and optical imaging to measure non-invasively expression and function of cytosine deaminase in a preclinical tumor model | Saccharomyces cerevisiae |
EC Number | Cloned (Comment) | Organism |
---|---|---|
2.4.2.9 | cytosine deaminase-UPRT-red fluorescence protein fusion proteins are expressed in Rattus norvegicus R-3327-AT cells | Homo sapiens |
3.5.4.1 | expression vector with cytosine deaminase fused to monomeric DsRed (mDsRed), expression vector contains immediate early promoter of cytomegalovirus (CMV) and a hygromycin B resistance gene, transient transfection of COS-7 cells | Saccharomyces cerevisiae |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.5.4.1 | cytosine + H2O | Saccharomyces cerevisiae | - |
uracil + NH3 | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.4.2.9 | Homo sapiens | Q96BW1 | - |
- |
3.5.4.1 | Saccharomyces cerevisiae | Q12178 | - |
- |
EC Number | Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|---|
3.5.4.1 | additional information | - |
development of cell lines and animal xenograft models, expression and function of fusion constructs between cytosine deaminase and monomeric DsRed (mDsRed), analyzed by Western blot, flow cytometry, fluorescence microscopy, magnetic resonance spectroscopy, analysis of antitumoral effect of 5-fluorouracil (5-FU) and 5-fluorocytosine (5-FC) in transgenic background, increase of cytosine deaminase enhances the potential of gene-directed enzyme prodrug therapy, conversion of 5-fluorocytosine to 5-fluorouracil analyzed in mice bearing tumor xenografts with the fusion product between cytosine deaminase and monomeric DsRed (R3327-CD/mDsRed) | Saccharomyces cerevisiae |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.4.2.9 | uracil + 5-phospho-alpha-D-ribose 1-diphosphate | - |
Homo sapiens | UMP + diphosphate | - |
? | |
3.5.4.1 | 5-fluorocytosine + H2O | recombinant enzyme in gene therapy, expression analysis in transgenic mice with xenograft tumors, optical imaging technologies | Saccharomyces cerevisiae | 5-fluorouracil + NH3 | - |
? | |
3.5.4.1 | cytosine + H2O | - |
Saccharomyces cerevisiae | uracil + NH3 | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.4.2.9 | UPRT | - |
Homo sapiens |
3.5.4.1 | CD | - |
Saccharomyces cerevisiae |